Inflammatory processes In diet-Induced pancreatic cancer promotion
Inflammatory processes In diet-Induced pancreatic cancer promotion
批准号:
8561427
负责人:
Guido Erwin Michael Eibl
金额:
$20.08万
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-08-01 至 2017-07-31
关键词:
Animal FeedAnimal ModelAnti-Inflammatory AgentsAnti-inflammatoryCaloriesCell Culture SystemCellsChronic DiseaseDevelopmentDietDietary SupplementationDinoprostoneDiseaseDoseEconomicsEicosanoidsEnvironmentFatty acid glycerol estersFish OilsGenetic EngineeringGrowthGrowth and Development functionHealthHistologicIn VitroIncidenceInflammationInflammation MediatorsInflammatoryInflammatory InfiltrateInflammatory ResponseInstructionLesionMalignant NeoplasmsMalignant neoplasm of pancreasMediatingNon-MalignantObesityObesity associated cancerOilsOmega-3 Fatty AcidsOral AdministrationOutcomePancreasPancreatic AdenocarcinomaPancreatic Intraepithelial NeoplasiaPharmaceutical PreparationsPlayProcessProstaglandinsPublishingResearch PersonnelRoleSignal PathwaySocietiesStagingTestingTransgenic MiceXenograft procedurecancer preventiondietary supplementsfeedingmacrophagemouse modelpreventprogramsreceptortumor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There is substantial evidence that the Western-style diet, rich in fats and calories, is a critical factor in the
development of obesity and other chronic diseases, including cancer. Although the underlying mechanisms
are likely multi-faceted, inflammation certainly plays an important role in High Fat Diet-induced obesity and
cancer. Infiltrating inflammatory cells as well as systemic and local levels of pro-inflammatory mediators
provide in ideal micro-milieu for tumor development Anti-inflammatory strategies have been shown in many
animal models to delay or prevent the development of cancers and are widely considered intriguing
approaches for cancer prevention. Our preliminary studies have shown that a high fat, high calorie diet
(HFCD) in the presence of an inflammatory micro-environment substantially accelerates the development
and progression of pancreatic cancer precursor lesions in a genetically engineered animal model of
pancreatic cancer development Furthermore, our previous published studies have demonstrated that oral
administration of an anti-inflammatory drug delays the progression of pancreatic cancer precursor lesions in
the conditional Kras mouse model of pancreatic cancer development. In addition, dietary supplementation of
fish oil inhibited pancreatic cancer grov\rth in a xenograft mouse model, which was accompanied by reduced
levels of pro-inflammatory prostaglandin species. The overarching hypothesis of this Project is that a HFCD
promotes pancreatic cancer development and growth. This effect mediated and accelerated by the presence
of an inflammatory micro-environment. Targeting the inflammatory response may prevent pancreatic cancer
development promoted by the HFCD. To test our hypothesis the following three Specific Aims are proposed.
1) To determine the importance of pancreatic inflammation in HFCD-induced pancreatic cancer
development, 2) to characterize the importance of eicosanoids in HFCD-induced pancreatic cancer
development and investigate their mechanisms, and 3) to determine the efficacy of fish oil as an anti-
inflammatory strategy to reduce pancreatic cancer development. State-of-the-art genetically engineered
animal models will be utilized to test the hypotheses. Underlying mechanisms will be dissected in cell culture
systems that mimic the different stages of pancreatic cancer development.
RELEVANCE (See instructions):
We anticipate proving our hypothesis that strategies aimed at inhibiting the inflammatory component, e.g.
through fish oil, significantly delay or prevent the tumor-promoting effects of the high fat, high calohe diet.
Since today fish oil is widely used as a general health-promoting dietary supplement, our studies will provide
the scientific rationale for the use of fish oil to prevent pancreatic cancer and elucidate its mechanism. Our
results may also be transferable to other obesity-related cancer and even non-malignant chronic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
-
批准号:10409304
-
项目类别:
-
资助金额:$21.88万
-
财政年份:2022
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Interaction between Chronic Stress and Obesity in Pancreatic Cancer Progression
-
批准号:10612088
-
项目类别:
-
资助金额:$17.87万
-
财政年份:2022
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
-
批准号:10398844
-
项目类别:
-
资助金额:$112.28万
-
财政年份:2020
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma
-
批准号:10605224
-
项目类别:
-
资助金额:$112.28万
-
财政年份:2020
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
-
批准号:10398845
-
项目类别:
-
资助金额:$23.84万
-
财政年份:2020
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Core 1: Animal and Cell Model Core
-
批准号:10605252
-
项目类别:
-
资助金额:$28.57万
-
财政年份:2020
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Core 1: Animal and Cell Model Core
-
批准号:10398850
-
项目类别:
-
资助金额:$28.7万
-
财政年份:2020
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
-
批准号:10605225
-
项目类别:
-
资助金额:$23.81万
-
财政年份:2020
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Animal Core
-
批准号:8561432
-
项目类别:
-
资助金额:$25.83万
-
财政年份:2013
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
-
批准号:8337028
-
项目类别:
-
资助金额:$125.35万
-
财政年份:2012
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Animal Core
-
批准号:8373952
-
项目类别:
-
资助金额:$27.01万
-
财政年份:2012
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
-
批准号:8520265
-
项目类别:
-
资助金额:$120.7万
-
财政年份:2012
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
-
批准号:8712196
-
项目类别:
-
资助金额:$123.79万
-
财政年份:2012
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Inflammatory processes In diet-Induced pancreatic cancer promotion
-
批准号:8373905
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2012
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
Targeting diet-induced promotion of Kras-initiated pancreatic adenocarcinoma
-
批准号:9105358
-
项目类别:
-
资助金额:$130.45万
-
财政年份:2012
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
-
批准号:8068890
-
项目类别:
-
资助金额:$28.38万
-
财政年份:2007
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
-
批准号:7617714
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
-
批准号:7314801
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
-
批准号:7479413
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
-
批准号:7825489
-
项目类别:
-
资助金额:$29.26万
-
财政年份:2007
-
负责人:Guido Erwin Michael Eibl
-
依托单位:
海外基金